HG-14-10-04
Cat. No.:YN440348
产品名称: | HG-14-10-04 |
CAS No.: | 1356962-34-9 |
Chemical Name: | 5-chloro-4-(1H-indol-3-yl)-N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2-pyrimidinamine |
Synonyms: | HG-14-10-04;[5-Chloro-4-(1H-indol-3-yl)-pyrimidin-2-yl]-{2-methoxy-4-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-phenyl}-amine;5-Chloro-4-(1H-indol-3-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidin-2-amine;5-chloro-4-(1H-ind |
分子量: | 532.08 |
分子式: | C₂₉H₃₄ClN₇O |
SMILES: | ClC1=CN=C(NC2=CC=C(N3CCC(N4CCN(C)CC4)CC3)C=C2OC)N=C1C5=CNC6=CC=CC=C65 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | HG-14-10-04 (example 10) is a potent and specificALKinhibitor withIC50of 20 nM. |
IC50和靶点: | [{name:"EGFRLR/TM:15.6 nM (IC50)"},{name: "EGFR19del/TM/CS:22.6 nM (IC50)"},{name: "EGFRLR/TM/CS:124.5 nM (IC50)"},{name: "ALK:20 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Aquila, B., Kamhi, V., Peng, B., et al.Preparation of substituted pyrimidinamines as ALK kinase inhibitorsUS20120028924A1,1-54(2012)